SCHEMBL17845894

SCHEMBL17845894

Nc1cccc(F)c1CN1CCOCC1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 5/20 0.68
ALDH1A1 P00352 3/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
CXCR4 P61073 1/20 0.47
PIK3CD O00329 1/20 0.47
PIK3C2B O00750 1/20 0.47
MTOR P42345 1/20 0.47
PIK3CG P48736 1/20 0.47
KDM4E B2RXH2 4/20 0.46
NCF1 P14598 1/20 0.46
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GRIN2B Q13224 1/20 0.45
HTT P42858 1/20 0.42
MAPT P10636 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
DRD4 P21917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24018806 0.81 CYP2A13 (0.64) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL5269119 0.81 KDM4E (0.56) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL17857222 0.81 CYP2A13 (0.57) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL24783575 0.81 CYP2A13 (0.68) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL4107051 0.81 CYP2A13 (1.00) CYP2A13ALDH1A1KMT2AMEN1KDM4E
SCHEMBL19760571 0.80 CYP2A13 (0.50) CYP2A13ALDH1A1KMT2AMEN1CXCR4
Ammonia Solution, Strong SCHEMBL5275016 0.79 KDM4E (0.55) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL249086 0.77 CYP2A13 (0.61) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL22479885 0.77 CYP2A13 (0.62) CYP2A13ALDH1A1KMT2AMEN1CXCR4
SCHEMBL20605347 0.77 ALDH1A1 (0.53) CYP2A13ALDH1A1KMT2AMEN1CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233862-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS 3 INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2017-10-25 EP disclosed
WO-2016097347-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS ΡΙ3Κβ INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2016-06-23 WO disclosed